Effects of in vitro azithromycin treatment on bronchial epithelial antiviral immunity in asthma phenotypes

BackgroundAzithromycin (AZM) effectively reduces asthma exacerbations and enhances bronchial epithelial cell (BEC) antiviral immunity in vitro. However, its clinical impact on different asthma phenotypes is not fully elucidated and differences in treatment response to AZM may be attributable to diff...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Muzhda Ghanizada, Sofia Malm Tillgren, Louis Praeger-Jahnsen, Nihaya Mahmoud Said, Sisse Ditlev, Helle Frost Andreassen, Nanna Dyhre-Petersen, Samuel Cerps, Asger Sverrild, Celeste Porsbjerg, Lena Uller, Therese Lapperre, Mandy Menzel
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-06-01
Sarja:	Frontiers in Allergy
Aiheet:	asthma exacerbation antiviral immunity atopy rhinovirus bronchial epithelial cell azithromycin (AZM)
Linkit:	https://www.frontiersin.org/articles/10.3389/falgy.2025.1605109/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!